Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer

被引:1
作者
Arrieta, Oscar [1 ]
Bolano-Guerra, Laura Margarita [1 ]
Caballe-Perez, Enrique [1 ]
Lara-Mejia, Luis [1 ]
Turcott, Jenny G. [1 ]
Gutierrez, Salvador [1 ]
Lozano-Ruiz, Francisco [2 ]
Cabrera-Miranda, Luis [1 ]
Arroyave-Ramirez, Andres Mauricio [3 ]
Maldonado-Magos, Federico [4 ]
Corrales, Luis [5 ]
Martin, Claudio [6 ]
Gomez-Garcia, Ana Pamela [1 ]
Cacho-Diaz, Bernardo [7 ]
Cardona, Andres F. [8 ]
机构
[1] Inst Nacl Cancerol INCan, Dept Thorac Oncol, Thorac Oncol Unit, Mexico City, Mexico
[2] Hosp Med Sur, Radioncol Dept, Mexico City, Mexico
[3] Hosp Med Sur, Med Oncol Dept, Mexico City, Mexico
[4] Inst Nacl Cancerol INCan, Radiotherapy Unit, Mexico City, Mexico
[5] Hosp San Juan Dios, Oncol Dept, San Jose, Costa Rica
[6] Alexander Fleming Inst, Thorac Oncol Unit, Buenos Aires, Argentina
[7] Inst Nacl Cancerol INCan, Neurooncol Unit, Mexico City, Mexico
[8] Luis Carlos Sarmiento Angulo Canc Treatment & Res, Direct Res & Educ, Canc Treatment & Res Cente CTIC, Bogota, Colombia
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
central nervous system; tumor diameter; perilesional edema; lung adenocarcinoma; lung cancer; local therapy; radiation therapy; PROPHYLACTIC CRANIAL IRRADIATION; QUALITY-OF-LIFE; RADIATION-THERAPY; PROGNOSTIC-FACTORS; RISK; BEVACIZUMAB; DIAGNOSIS; SURVIVAL; OUTCOMES; IMPACT;
D O I
10.3389/fonc.2023.1251620
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Different prognostic scales exist in patients with brain metastasis, particularly in lung cancer. The Graded Prognostic Assessment for lung cancer using molecular markers (Lung-molGPA index) for brain metastases is a powerful prognostic tool that effectively identifies patients at different risks. However, these scales do not include perilesional edema diameter (PED) associated with brain metastasis. Current evidence suggests that PED might compromise the delivery and efficacy of radiotherapy to treat BM. This study explored the association between radiotherapy efficacy, PED extent, and gross tumor diameter (GTD).Aim: The aim of this study was to evaluate the intracranial response (iORR), intracranial progression-free survival (iPFS), and overall survival (OS) according to the extent of PED and GT.Methods: Out of 114 patients with BM at baseline or throughout the disease, 65 were eligible for the response assessment. The GTD and PED sum were measured at BM diagnosis and after radiotherapy treatment. According to a receiver operating characteristic (ROC) curve analysis, cutoff values were set at 27 mm and 17 mm for PED and GT, respectively.Results: Minor PED was independently associated with a better iORR [78.8% vs. 50%, OR 3.71 (95% CI 1.26-10.99); p = 0.018] to brain radiotherapy. Median iPFS was significantly shorter in patients with major PED [6.9 vs. 11.8 months, HR 2.9 (95% CI 1.7-4.4); p < 0.001] independently of other prognostic variables like the Lung-molGPA and GTD. A major PED also negatively impacted the median OS [18.4 vs. 7.9 months, HR 2.1 (95% CI 1.4-3.3); p = 0.001].Conclusion: Higher PED was associated with an increased risk of intracranial progression and a lesser probability of responding to brain radiotherapy in patients with metastatic lung cancer. We encourage prospective studies to confirm our findings.
引用
收藏
页数:11
相关论文
共 40 条
  • [1] Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study
    Alemany, Montse
    Domenech, Marta
    Argyriou, Andreas A.
    Vilarino, Noelia
    Majos, Carles
    Naval-Baudin, Pablo
    Lucas, Anna
    Palmero, Ramon
    Simo, Marta
    Nadal, Ernest
    Bruna, Jordi
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [2] Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial)
    Arrieta, Oscar
    Maldonado, Federico
    Turcott, Jenny G.
    Lucia Zatarain-Barron, Zyanya
    Barron, Feliciano
    Blake-Cerda, Monika
    Antonio Cabrera-Miranda, Luis
    Cardona, Andres F.
    de la Garza, Jaime G.
    Rosell, Rafael
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (05): : 1442 - 1450
  • [3] Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease
    Arrieta, Oscar
    Aviles Salas, Alejandro
    Cardona, Andres F.
    Diaz-Garcia, Diego
    Lara-Mejia, Luis
    Escamilla, Ixel
    Pereira Garcia, Ariana
    Caballe Perez, Enrique
    Raez, Luis E.
    Rolfo, Christian
    Rosell, Rafael
    [J]. LUNG CANCER, 2021, 155 : 183 - 190
  • [4] An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small-Cell Lung Cancer
    Ashworth, Allison B.
    Senan, Suresh
    Palma, David A.
    Riquet, Marc
    Ahn, Yong Chan
    Ricardi, Umberto
    Congedo, Maria T.
    Gomez, Daniel R.
    Wright, Gavin M.
    Melloni, Giulio
    Milano, Michael T.
    Sole, Claudio V.
    De Pas, Tommaso M.
    Carter, Dennis L.
    Warner, Andrew J.
    Rodrigues, George B.
    [J]. CLINICAL LUNG CANCER, 2014, 15 (05) : 346 - 355
  • [5] AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
    Batchelor, Tracy T.
    Sorensen, A. Gregory
    di Tomaso, Emmanuelle
    Zhang, Wei-Ting
    Duda, Dan G.
    Cohen, Kenneth S.
    Kozak, Kevin R.
    Cahill, Daniel P.
    Chen, Poe-Jou
    Zhu, Mingwang
    Ancukiewicz, Marek
    Mrugala, Maciej M.
    Plotkin, Scott
    Drappatz, Jan
    Louis, David N.
    Ivy, Percy
    Scadden, David T.
    Benner, Thomas
    Loeffler, Jay S.
    Wen, Patrick Y.
    Jain, Rakesh K.
    [J]. CANCER CELL, 2007, 11 (01) : 83 - 95
  • [6] Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases
    Berghoff, Anna Sophie
    Breckwoldt, Michael Oliver
    Riedemann, Lars
    Karimian-Jazi, Kianush
    Loew, Sarah
    Schlieter, Franziska
    Furtner, Julia
    Cinci, Marc
    Thomas, Michael
    Strowitzki, Moritz J.
    Marme, Frederik
    Michel, Laura L.
    Schmidt, Thomas
    Jaeger, Dirk
    Bendszus, Martin
    Preusser, Matthias
    Wick, Wolfgang
    Winkler, Frank
    [J]. NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [7] Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study
    Besse, Benjamin
    Le Moulec, Sylvestre
    Mazieres, Julien
    Senellart, Helene
    Barlesi, Fabrice
    Chouaid, Christos
    Dansin, Eric
    Berard, Henri
    Falchero, Lionel
    Gervais, Radj
    Robinet, Gilles
    Ruppert, Anne-Marie
    Schott, Roland
    Lena, Herve
    Clement-Duchene, Christelle
    Quantin, Xavier
    Souquet, Pierre Jean
    Tredaniel, Jean
    Moro-Sibilot, Denis
    Perol, Maurice
    Madroszyk, Anne-Catherine
    Soria, Jean-Charles
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (08) : 1896 - 1903
  • [8] Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial
    Brown, Paul D.
    Ballman, Karla V.
    Cerhan, Jane H.
    Anderson, S. Keith
    Carrero, Xiomara W.
    Whitton, Anthony C.
    Greenspoon, Jeffrey
    Parney, Ian F.
    Laack, Nadia N. I.
    Ashman, Jonathan B.
    Bahary, Jean-Paul
    Hadjipanayis, Costas G.
    Urbanic, James J.
    Barker, Fred G., II
    Farace, Elana
    Khuntia, Deepak
    Giannini, Caterina
    Buckner, Jan C.
    Galanis, Evanthia
    Roberge, David
    [J]. LANCET ONCOLOGY, 2017, 18 (08) : 1049 - 1060
  • [9] Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer
    Burudpakdee, C.
    Wong, W.
    Seetasith, A.
    Corvino, F. A.
    Yeh, W.
    Gubens, M.
    [J]. LUNG CANCER, 2018, 119 : 103 - 111
  • [10] Identification of a high-risk group for brain metastases in non-small cell lung cancer patients
    Cacho-Diaz, Bernardo
    Denisse Cuapatencatl, Laura
    Antonio Rodriguez, Jose
    Jazmin Garcilazo-Reyes, Ytel
    Reynoso-Noveron, Nancy
    Arrieta, Oscar
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (01) : 101 - 106